Pancreatic Cancer Research

ResearcherThe Cancer Institute HospitalActive in the last 2 years

Hiroki Nakagawa

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-9077-9289; OpenAlex author ID A5110899651. Sources: OpenAlex.

Their work

Papers
7
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2022: 1 paper · 2023: 3 papers · 2024: 2 papers · 2025: 1 paper

Papers 7

  1. Efficacy of Anamorelin in Advanced Pancreatic Cancer Patients with a Poor Performance Status. Co-author DOI 10.2169/internalmedicine.3577-24↗
  2. Outcomes of 6-mm diameter fully covered self-expandable metal stents for preoperative biliary drainage in pancreatic cancer. Co-author DOI 10.1002/deo2.360↗
  3. Bone loss over time and risk of osteoporosis in advanced pancreatic cancer. Co-author DOI 10.1093/jjco/hyae028↗
  4. Prognostic impact of osteosarcopenia in patients with advanced pancreatic cancer receiving gemcitabine plus nab-paclitaxel. Co-author DOI 10.1016/j.pan.2023.02.002↗
  5. Impact of the Extent of Weight Loss before Administration on the Efficacy of Anamorelin in Advanced Pancreatic Cancer Patients with Cachexia. Co-author DOI 10.2169/internalmedicine.0730-22↗
  6. Treatment Outcomes and Prognostic Factors of Gemcitabine Plus Nab-Paclitaxel as Second-Line Chemotherapy after Modified FOLFIRINOX in Unresectable Pancreatic C… Co-author DOI 10.3390/cancers15020358↗
  7. Impact of the COVID-19 Pandemic on the Management and End-of-life Care of Unresectable Pancreatic Cancer. Co-author DOI 10.2169/internalmedicine.0492-22↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Takashi Sasaki · 7 shared papers, 2022–2025 · strength 1.25
  2. Takeshi Okamoto · 7 shared papers, 2022–2025 · strength 1.25
  3. Tsuyoshi Takeda · 7 shared papers, 2022–2025 · strength 1.25
  4. Akiyoshi Kasuga · 7 shared papers, 2022–2025 · strength 1.25
  5. Masato Ozaka · 7 shared papers, 2022–2025 · strength 1.25
  6. Takafumi Mie · 7 shared papers, 2022–2025 · strength 1.25
  7. Naoki Sasahira · 7 shared papers, 2022–2025 · strength 1.25
  8. Takaaki Furukawa · 6 shared papers, 2022–2025 · strength 1.05
  9. Masato Matsuyama · 4 shared papers, 2022–2023 · strength 0.62
  10. Takahisa Matsuda · 1 shared paper, 2024 · strength 0.21
  11. Tsuyoshi Hamada · 1 shared paper, 2023 · strength 0.16
  12. Yuto Yamada · 1 shared paper, 2022 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.